Holistic HIV care with HAART
BMJ 2007; 335 doi: https://doi.org/10.1136/sbmj.0712458 (Published 01 December 2007) Cite this as: BMJ 2007;335:0712458- Alison Bradley, third year medical student1,
- Anthony J France, consultant physician2
- 1University of Dundee
- 2Dundee DD1 9SY
Highly active antiretroviral therapy (HAART) has redefined HIV in industrial countries as a chronic rather than a terminal illness, changing the doctor's role from carer to treatment manager.1 But patients are more than their CD4 and T cell counts. Why should increasing technology in HIV care replace and not complement holistic care? By exploring stigma, psychosocial factors, palliative care, and the controversy surrounding certification of death, this article considers the holistic role of doctors caring for patients with HIV in the HAART era.
New treatment, old stigma
In this information age many in the general public would prefer a diagnosis of cardiac failure with impaired left ventricular systolic function (five year survival 25.2%)2 or non-small cell lung carcinoma (eight month survival with chemotherapy)3 rather than HIV, despite its better prognosis (three year survival up to 50%).4 This shows the unremitting stigma surrounding HIV that has penetrated the HAART era because of several perceptions.
Firstly, one perception is that HIV is a moral judgment passed on through avoidable and socially unacceptable behaviours.5 Just as a lawyer representing a serial killer is deemed to share in the evil of the accused so a health professional caring for patients with HIV faces stigmatisation for condoning this “evil.” Secondly, HIV is perceived to be lethal and incurable, with patients posing a risk to others.5
Why should this be a concern of doctors? Stigma perpetuates fear that prevents people from seeking HIV testing and that prevents affected people, including families, from accessing services. This prevents access to education and empowerment to follow advice to reduce risk. Stigma reduces health status by increasing stress …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.